#RareDiseasesNews: The Rare Disease drug market is a growing and competitve environment "nearly half of all agents approved by the FDA last year had previously received orphan designation". So, what should be your next move?
Find out more HERE
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2018
Categories |